Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries

被引：34

作者：

Wong, Charlene A. ^{[1
]}

Saraiya, Mona ^{[1
]}

Hariri, Susan ^{[2
]}

Eckert, Linda ^{[3
]}

Howlett, Roberta I. ^{[4
]}

Markowitz, Lauri E. ^{[2
]}

Brotherton, Julia M. L. ^{[5
]}

Sinka, Katy ^{[6
]}

Martinez-Montanez, Olga G. ^{[7
]}

Kjaer, Susanne K. ^{[8
]}

Dunne, Eileen F. ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA 30333 USA

[2] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA

[3] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA

[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[5] Victorian Cytol Serv, Melbourne, Vic, Australia

[6] Hlth Protect Scotland, Immunisat & Resp Sect, Glasgow, Lanark, Scotland

[7] Natl Ctr Reprod Hlth & Gender Equ, Minist Hlth, Mexico City, DF, Mexico

[8] Univ Copenhagen, Rigshosp, Gynecol Clin, DK-2100 Copenhagen, Denmark

来源：

VACCINE | 2011年 / 29卷 / 05期

关键词：

HPV vaccine; Post marketing product surveillance; Cervical cancer; HUMAN-PAPILLOMAVIRUS TYPES; RECURRENT RESPIRATORY PAPILLOMATOSIS; CERVICAL-CANCER PREVENTION; PARTICLE VACCINE; SUSTAINED EFFICACY; FOLLOW-UP; WORLDWIDE; INFECTION; TYPE-18; BURDEN;

D O I：

10.1016/j.vaccine.2010.10.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on biologic outcomes in selected international areas (Australia, Canada, Mexico, the Nordic countries, Scotland, and the United States) that have adopted this vaccine. This summary of monitoring plans provides a background for discussing the challenges of vaccine monitoring in settings where resources and capacity may vary. A variety of approaches that depend on existing infrastructure and resources are planned or underway for monitoring HPV vaccine impact. Monitoring HPV vaccine impact on biologic outcomes is a complex and challenging task, but also plays an important role in documenting the benefit of vaccination, monitoring the progress of vaccination programs, and providing data to inform vaccination and disease prevention policies. Published by Elsevier Ltd.

引用

页码：878 / 885

页数：8

共 20 条

[1] Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries
Pindyck, Talia
Tate, Jacqueline E.
Bonkoungou, Isidore Juste O.
Armah, George
Mujuru, Hilda Angela
Rugambwa, Celse
Mwenda, Jason M.
Parashar, Umesh
VACCINE, 2019, 37 (40) : 6002 - 6007
[2] Monitoring HPV Vaccine Impact: Early Results and Ongoing Challenges
Hariri, Susan
Markowitz, Lauri
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (11): : 1633 - 1635
[3] Approaches to increase HPV vaccination rate in Germany - challenges and opportunities. A qualitative study
Schott, Evelyn
Schaller, Katrin
Mons, Ute
Ouedraogo, Nobila
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2022, 170 : 29 - 37
[4] Identifying key challenges and optimizing approaches for training of health care professionals for HPV vaccination programmes
Waheed, Dur-E-Nayab
Mumba, Mutale
Alfred, Driwale
Bogale, Mengistu
Rujumba, Joseph
Bakeera-Kitaka, Sabrina
Lweya, Thomas
Madhuri, Adhara
Karafillakis, Emilie
Vorsters, Alex
VACCINE, 2024, 42 (18) : S22 - S26
[5] National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects
Tsu, Vivien D.
LaMontagne, D. Scott
Atuhebwe, Phionah
Bloem, Paul N.
Ndiaye, Cathy
PREVENTIVE MEDICINE, 2021, 144
[6] COMPUTATIONAL ENZYME DESIGN APPROACHES WITH SIGNIFICANT BIOLOGICAL OUTCOMES: PROGRESS AND CHALLENGES
Li, Xiaoman
Zhang, Ziding
Song, Jiangning
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2012, 2 (03):
[7] Challenges of diatom-based biological monitoring and assessment of streams in developing countries
Taurai Bere
Environmental Science and Pollution Research, 2016, 23 : 5477 - 5486
[8] Challenges of diatom-based biological monitoring and assessment of streams in developing countries
Bere, Taurai
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2016, 23 (06) : 5477 - 5486
[9] Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, Sue J.
O'Shea, Meredith
Campos, Nicole Gastineau
Diaz, Mireia
Sweet, Steven
Kim, Sun-Young
VACCINE, 2008, 26 (32) : 4080 - 4093
[10] The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
Hariri, Susan
Unger, Elizabeth R.
Powell, Suzanne E.
Bauer, Heidi M.
Bennett, Nancy M.
Bloch, Karen C.
Niccolai, Linda M.
Schafer, Sean
Markowitz, Lauri E.
CANCER CAUSES & CONTROL, 2012, 23 (02) : 281 - 288

← 1 2 →